The therapeutic indications of cefpodoxime are based on its antibacterial activity and pharmacokinetic properties.
In children, they are limited to the treatment of infections due to bacteria susceptible to cefpodoxime, in particular:
• Acute sinusitis media.
• Documented group A beta-hemolytic streptococcal sore throat.
• Sinusitis.
• Lower respiratory tract infections.